PDGFRA and neoplasm: BM-derived MSCs are recruited to breast and lung tumors, differentiate to a distinct subpopulation of CAFs that lack PDGFRα, promote tumor growth and angiogenesis via expression of Clusterin, and end up as a diminished PDGFRα-expressing resident CAFs population [150].